Key Insights

Highlights

Success Rate

86% trial completion

Published Results

43 trials with published results (19%)

Research Maturity

135 completed trials (60% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

9.8%

22 terminated out of 224 trials

Success Rate

86.0%

-0.6% vs benchmark

Late-Stage Pipeline

14%

31 trials in Phase 3/4

Results Transparency

32%

43 of 135 completed with results

Key Signals

43 with results86% success22 terminated

Data Visualizations

Phase Distribution

139Total
Not Applicable (52)
Early P 1 (2)
P 1 (22)
P 2 (32)
P 3 (24)
P 4 (7)

Trial Status

Completed135
Unknown48
Terminated22
Withdrawn10
Recruiting5
Not Yet Recruiting2

Trial Success Rate

86.0%

Benchmark: 86.6%

Based on 135 completed trials

Clinical Trials (224)

Showing 20 of 20 trials
NCT04359836Suspended

A Study to Explore the Role of Gut Flora in COVID-19 Infection

NCT04393961Not ApplicableWithdrawn

At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study

NCT06128382Phase 1CompletedPrimary

First-in-human Study to Evaluate the Safety and Immunogenicity of Three Dose Levels of the OVX033 Coronavirus Vaccine Candidate in Healthy Volunteers

NCT07813481Not Yet Recruiting

ELderly REspiratory VIral Cohort

NCT04772170Recruiting

Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies

NCT07221097CompletedPrimary

Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses

NCT04483973Phase 2Completed

SPI-1005 Treatment in Severe COVID-19 Patients

NCT04365101Phase 1TerminatedPrimary

Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19

NCT04259892CompletedPrimary

Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.

NCT04376034Phase 3Completed

Convalescent Plasma Collection and Treatment in Pediatrics and Adults

NCT06099795Not ApplicableRecruiting

Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2

NCT04568148Active Not Recruiting

COVID-19 Biorepository

NCT04336215CompletedPrimary

Rutgers COVID-19 Cohort Study

NCT04605926Phase 3WithdrawnPrimary

A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19

NCT04367857Recruiting

ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers

NCT04306393Phase 2Completed

Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19

NCT04341792Completed

Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient

NCT04331886Completed

An Observational Study of Patients With Coronavirus Disease 2019

NCT04581954Phase 1CompletedPrimary

Inflammatory Signal Inhibitors for COVID-19 (MATIS)

NCT04824443Phase 1Completed

Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19

Scroll to load more

Research Network

Activity Timeline